JPH0531540B2 - - Google Patents

Info

Publication number
JPH0531540B2
JPH0531540B2 JP59152582A JP15258284A JPH0531540B2 JP H0531540 B2 JPH0531540 B2 JP H0531540B2 JP 59152582 A JP59152582 A JP 59152582A JP 15258284 A JP15258284 A JP 15258284A JP H0531540 B2 JPH0531540 B2 JP H0531540B2
Authority
JP
Japan
Prior art keywords
urea
basic amino
amino acid
acid salt
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59152582A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6130567A (ja
Inventor
Takeshi Yanagida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP15258284A priority Critical patent/JPS6130567A/ja
Publication of JPS6130567A publication Critical patent/JPS6130567A/ja
Publication of JPH0531540B2 publication Critical patent/JPH0531540B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP15258284A 1984-07-23 1984-07-23 尿素の安定化法 Granted JPS6130567A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15258284A JPS6130567A (ja) 1984-07-23 1984-07-23 尿素の安定化法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15258284A JPS6130567A (ja) 1984-07-23 1984-07-23 尿素の安定化法

Publications (2)

Publication Number Publication Date
JPS6130567A JPS6130567A (ja) 1986-02-12
JPH0531540B2 true JPH0531540B2 (enExample) 1993-05-12

Family

ID=15543613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15258284A Granted JPS6130567A (ja) 1984-07-23 1984-07-23 尿素の安定化法

Country Status (1)

Country Link
JP (1) JPS6130567A (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558172Y2 (ja) * 1992-07-02 1997-12-17 旭光学工業株式会社 内視鏡の送気装置
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
JP2006524199A (ja) * 2003-04-24 2006-10-26 ロレアル 美容的ピーリング方法
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
MX2008014024A (es) 2006-05-04 2008-11-14 Boehringer Ingelheim Int Formas poliformas.
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
BRPI0721862B1 (pt) 2007-07-09 2016-03-15 Symrise Ag preparação compreendendo sais solúveis estáveis de ácido fenilbenzimidazol sulfônico, e uso de aminoácidos básicos
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2504002B1 (en) 2009-11-27 2019-10-09 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
ES2929025T3 (es) 2012-05-14 2022-11-24 Boehringer Ingelheim Int Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
JP6115086B2 (ja) * 2012-11-13 2017-04-19 味の素株式会社 アミノ酸化合物の酢酸塩を含有する化粧料組成物
WO2014159816A1 (en) 2013-03-14 2014-10-02 Siemens Healthcare Diagnostics Inc. CONTROL OF pH IN AQUEOUS UREA-CONTAINING SOLUTIONS UTILIZING AMINO ACID-CONTAINING COMPOSITIONS
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5550925A (en) * 1978-10-09 1980-04-14 Sakura Kogyo Kk Muffler silencer producing device
US4424232A (en) * 1982-05-19 1984-01-03 Parkinson Richard W Treatment of herpes simplex
JPS5920217A (ja) * 1982-07-27 1984-02-01 Kawaken Fine Chem Co Ltd 尿素を安定に含む水性ゼリ−状組成物

Also Published As

Publication number Publication date
JPS6130567A (ja) 1986-02-12

Similar Documents

Publication Publication Date Title
JPH0531540B2 (enExample)
JPH0330566B2 (enExample)
DE3427240A1 (de) Antiinflammatorische und antipyretische creme
EP1226822B1 (en) Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
JPS59134772A (ja) 尿素の安定化法
WO1989005143A1 (en) Method of treating skin disorders
JPH0527618B2 (enExample)
JPS5920217A (ja) 尿素を安定に含む水性ゼリ−状組成物
JPH0531541B2 (enExample)
JPH0577648B2 (enExample)
JP4926354B2 (ja) 皮膚外用剤
JPS6130509A (ja) 皮膚外用剤
JPS6245202B2 (enExample)
JPS6147457A (ja) 尿素の安定化法
JPS6147456A (ja) 尿素の安定化法
JPH08268861A (ja) 皮膚外用剤
RU2036640C1 (ru) Мазь для лечения заболеваний с нарушением керотинизации и целостности кожи
JPS6220166B2 (enExample)
JPS61200904A (ja) 外用尿素製剤
US2230084A (en) Astringent preparation
JPH01301612A (ja) 育毛剤
JP2883662B2 (ja) 皮膚化粧料
JPH0142922B2 (enExample)
JPH08268860A (ja) 皮膚外用剤
US3862318A (en) Microbiocidal naphthenyl imidazolines